Literature DB >> 21664473

Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD.

.   

Abstract

In 2005, the National Institutes of Health sponsored a Consensus Development Project on Criteria for Clinical Trials in chronic graft-versus-host (cGVHD) to achieve consensus about key elements of cGVHD research, including definitions for diagnosis, severity scoring, and response measures. To test these proposed definitions, a multicenter prospective cohort study of people with cGVHD is ongoing. This study will evaluate the performance of proposed prognostic factors, measures of disease activity, and surrogate endpoints for therapeutic response. Data are collected at 6-month intervals in a heterogeneous population of patients reflecting modern transplant techniques and posttransplantation clinical management (target enrollment 672 with cGVHD from 10 transplantation centers). This report describes the rationale, design, and methods of the cGVHD cohort study, and invites other investigators to collaborate with the Consortium to analyze data or specimens.
Copyright © 2011 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21664473      PMCID: PMC4016312          DOI: 10.1016/j.bbmt.2011.05.007

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  29 in total

1.  Multiple imputation of baseline data in the cardiovascular health study.

Authors:  Alice M Arnold; Richard A Kronmal
Journal:  Am J Epidemiol       Date:  2003-01-01       Impact factor: 4.897

2.  Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation.

Authors:  T L Kiss; M Abdolell; N Jamal; M D Minden; J H Lipton; H A Messner
Journal:  J Clin Oncol       Date:  2002-05-01       Impact factor: 44.544

3.  Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.

Authors:  Joseph Pidala; Brenda Kurland; Xiaoyu Chai; Navneet Majhail; Daniel J Weisdorf; Steven Pavletic; Corey Cutler; David Jacobsohn; Jeanne Palmer; Sally Arai; Madan Jagasia; Stephanie J Lee
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

4.  Measurement properties of the activities scale for kids.

Authors:  N L Young; J I Williams; K K Yoshida; J G Wright
Journal:  J Clin Epidemiol       Date:  2000-02       Impact factor: 6.437

5.  Development and validation of a scale to measure symptoms of chronic graft-versus-host disease.

Authors:  Stephanie k Lee; E Francis Cook; Robert Soiffer; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2002       Impact factor: 5.742

6.  Chronic graft-versus-host disease: a prospective cohort study.

Authors:  Mukta Arora; Linda J Burns; Stella M Davies; Margaret L Macmillan; Todd E Defor; Wesley J Miller; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2003-01       Impact factor: 5.742

Review 7.  Chronic graft-versus-host disease.

Authors:  Stephanie J Lee; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2003-04       Impact factor: 5.742

8.  Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.

Authors:  Mary E D Flowers; Pablo M Parker; Laura J Johnston; Alice V B Matos; Barry Storer; William I Bensinger; Rainer Storb; Frederick R Appelbaum; Stephen J Forman; Karl G Blume; Paul J Martin
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

9.  Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

Authors:  Stephanie J Lee; John P Klein; A John Barrett; Olle Ringden; Joseph H Antin; Jean-Yves Cahn; Matthew H Carabasi; Robert Peter Gale; Sergio Giralt; Gregory A Hale; Osman Ilhan; Philip L McCarthy; Gerard Socie; Leo F Verdonck; Daniel J Weisdorf; Mary M Horowitz
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

10.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

Authors:  H M Shulman; K M Sullivan; P L Weiden; G B McDonald; G E Striker; G E Sale; R Hackman; M S Tsoi; R Storb; E D Thomas
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

View more
  40 in total

1.  Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.

Authors:  David A Jacobsohn; Brenda F Kurland; Joseph Pidala; Yoshihiro Inamoto; Xiaoyu Chai; Jeanne M Palmer; Sally Arai; Mukta Arora; Madan Jagasia; Corey Cutler; Daniel Weisdorf; Paul J Martin; Steven Z Pavletic; Georgia Vogelsang; Stephanie J Lee; Mary E D Flowers
Journal:  Blood       Date:  2012-07-06       Impact factor: 22.113

2.  Assessing the relationship between oral chronic graft-versus-host disease and global measures of quality of life.

Authors:  Joseph DePalo; Xiaoyu Chai; Stephanie J Lee; Corey S Cutler; Nathaniel Treister
Journal:  Oral Oncol       Date:  2015-08-12       Impact factor: 5.337

3.  Assessment of joint and fascia manifestations in chronic graft-versus-host disease.

Authors:  Yoshihiro Inamoto; Joseph Pidala; Xiaoyu Chai; Brenda F Kurland; Daniel Weisdorf; Mary E D Flowers; Jeanne Palmer; Sally Arai; David Jacobsohn; Corey Cutler; Madan Jagasia; Jenna D Goldberg; Paul J Martin; Steven Z Pavletic; Georgia B Vogelsang; Stephanie J Lee; Paul A Carpenter
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

4.  The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host Disease.

Authors:  Jocelyn S Gandelman; John Zic; Anna K Dewan; Stephanie J Lee; Mary Flowers; Corey Cutler; Joseph Pidala; Heidi Chen; Madan H Jagasia; Eric R Tkaczyk
Journal:  Biol Blood Marrow Transplant       Date:  2018-09-13       Impact factor: 5.742

5.  Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.

Authors:  Yi-Chen Sun; Xiaoyu Chai; Yoshihiro Inamoto; Joseph Pidala; Paul J Martin; Mary E D Flowers; Tueng T Shen; Stephanie J Lee; Madan Jagasia
Journal:  Biol Blood Marrow Transplant       Date:  2015-05-30       Impact factor: 5.742

6.  Dickkopf-related protein 3 is a novel biomarker for chronic GVHD after allogeneic hematopoietic cell transplantation.

Authors:  Yoshihiro Inamoto; Paul J Martin; Stephanie J Lee; Amin A Momin; Laura Tabellini; Lynn E Onstad; Joseph Pidala; Mary E D Flowers; Richard L Lawler; Hiroyuki Katayama; Samir Hanash; John A Hansen
Journal:  Blood Adv       Date:  2020-06-09

7.  Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium.

Authors:  Joseph Pidala; Xiaoyu Chai; Paul Martin; Yoshihiro Inamoto; Corey Cutler; Jeanne Palmer; Daniel Weisdorf; Steven Pavletic; Mukta Arora; Madan Jagasia; David Jacobsohn; Stephanie J Lee
Journal:  Biol Blood Marrow Transplant       Date:  2013-03-27       Impact factor: 5.742

8.  Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease.

Authors:  Yoshihiro Inamoto; Paul J Martin; Barry E Storer; Jeanne Palmer; Daniel J Weisdorf; Joseph Pidala; Mary E D Flowers; Mukta Arora; Madan Jagasia; Sally Arai; Xiaoyu Chai; Steven Z Pavletic; Georgia B Vogelsang; Stephanie J Lee
Journal:  Haematologica       Date:  2014-07-04       Impact factor: 9.941

9.  The Rare Diseases Clinical Research Network's organization and approach to observational research and health outcomes research.

Authors:  Jeffrey P Krischer; Rashmi Gopal-Srivastava; Stephen C Groft; David J Eckstein
Journal:  J Gen Intern Med       Date:  2014-08       Impact factor: 5.128

10.  Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.

Authors:  Areej El-Jawahri; Joseph Pidala; Yoshi Inamoto; Xiaoyu Chai; Nandita Khera; William A Wood; Corey Cutler; Mukta Arora; Paul A Carpenter; Jeanne Palmer; Mary Flowers; Daniel Weisdorf; Steven Pavletic; Samantha Jaglowski; Madan Jagasia; Stephanie J Lee; Yi-Bin Chen
Journal:  Biol Blood Marrow Transplant       Date:  2014-05-09       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.